Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Elia Insider Profile
4 Followers
Marc Elia, Director at SQZ Biotechnologies, holds ― shares in SQZ Biotechnologies (Ticker: SQZB), holds 1.86M shares in Fractyl Health, Inc. (Ticker: GUTS), holds 9.25M shares in Invivyd (Ticker: IVVD). Most recently, Marc Elia ― shares of SQZ Biotechnologies on ― for an estimated value of ―.
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-61.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Marc Elia holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marc Elia
Marc Elia's Trading History
SQZ Biotechnologies
―
Director
―
―
Invivyd
Aug 19, 2022
Director, See Remarks
Informative Buy
12.19M
$12.21M
Fractyl Health, Inc.
Feb 08, 2024
Director
Uninformative Buy
―
$7.78M
List of latest transactions for each holding click on a transaction to see Marc Elia's performance on stock
You May Also Like
Marc Elia insider profile FAQ
What is the percentage of profitable transactions made by Marc Elia?
The percentage of profitable transactions made by Marc Elia is 0%.
What is the average return per transaction made by Marc Elia?
The average return per transaction made by Marc Elia is -61.10%.
What stocks does Marc Elia hold?
Marc Elia holds: SQZB, IVVD, GUTS stocks.
What was Marc Elia’s latest transaction?
Marc Elia latest transaction was an Uninformative Buy of ―.
What was Marc Elia's most profitable transaction?
Marc Elia’s most profitable transaction was an Informative Buy of GUTS stock on February 8, 2024. The return on the trade was -59.70%.
What is Marc Elia's role in SQZ Biotechnologies?
Marc Elia's role in SQZ Biotechnologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.